Alterity Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Alterity Therapeutics has a total shareholder equity of A$17.6M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$22.2M and A$4.6M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$12.32m |
| Equity | AU$17.62m |
| Total liabilities | AU$4.57m |
| Total assets | AU$22.19m |
Recent financial health updates
We're Keeping An Eye On Alterity Therapeutics' (ASX:ATH) Cash Burn Rate
Jun 28
Is Alterity Therapeutics (ASX:ATH) In A Good Position To Invest In Growth?
Mar 07We're Hopeful That Alterity Therapeutics (ASX:ATH) Will Use Its Cash Wisely
May 16Here's Why We're Watching Alterity Therapeutics' (ASX:ATH) Cash Burn Situation
Jan 31Recent updates
Shareholders May Be More Conservative With Alterity Therapeutics Limited's (ASX:ATH) CEO Compensation For Now
Nov 23We're Keeping An Eye On Alterity Therapeutics' (ASX:ATH) Cash Burn Rate
Jun 28Is Alterity Therapeutics (ASX:ATH) In A Good Position To Invest In Growth?
Mar 07We're Hopeful That Alterity Therapeutics (ASX:ATH) Will Use Its Cash Wisely
May 16Here's Why We're Watching Alterity Therapeutics' (ASX:ATH) Cash Burn Situation
Jan 31How Much Is Alterity Therapeutics Limited (ASX:ATH) CEO Getting Paid?
Dec 09Financial Position Analysis
Short Term Liabilities: ATH's short term assets (A$22.0M) exceed its short term liabilities (A$4.5M).
Long Term Liabilities: ATH's short term assets (A$22.0M) exceed its long term liabilities (A$76.5K).
Debt to Equity History and Analysis
Debt Level: ATH is debt free.
Reducing Debt: ATH had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ATH has sufficient cash runway for 10 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: ATH is forecast to have sufficient cash runway for 10 months based on free cash flow estimates, but has since raised additional capital.